Iberogast (Milk Thistle Fruit Extract, Bitter Candytuft Fresh Plant Extract, Matricaria Liquid Extract, Menthae)

Milk Thistle Extract, together with other herbal components, contributes to Iberogast’s multi‑target action. It exerts anti‑inflammatory effects, modulates smooth‑muscle activity through calcium‑channel and muscarinic pathways, and supports liver function, collectively helping to calm gastrointestinal spasms and improve digestion.

The dosage of Iberogast is determined by the prescribing healthcare professional based on the patient’s age, condition severity and response to therapy. Patients should follow the prescriber’s instructions and the product label without self‑adjusting the amount.

Safety data for Iberogast in pregnancy and lactation are limited. It is generally advised to avoid use during pregnancy unless clearly needed, and to exercise caution while breastfeeding, discussing potential risks with a qualified healthcare provider.

To order Iberogast, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Unlike single‑active synthetic drugs, Iberogast combines several herbal extracts offering spasmolytic, anti‑inflammatory and pro‑kinetic actions simultaneously. This multi‑mechanistic profile can provide broader symptom relief for functional dyspepsia and IBS compared with agents that target only one pathway, though individual response varies.

Iberogast should be stored at ambient temperature, preferably below 25 °C. Keep the bottle tightly closed, in its original packaging, and protect it from moisture, direct sunlight and extreme temperature fluctuations to maintain product stability.

Iberogast is supplied as a liquid oral suspension. The recommended method is to measure the prescribed amount using the provided dosing device and swallow it directly or mix it with a small amount of water, as instructed by the prescriber.

Serious risks, though rare, include anaphylactic reactions, severe liver enzyme elevations and rare severe skin reactions such as Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience symptoms like difficulty breathing, rash, jaundice or unexplained abdominal pain.

Iberogast should be avoided by individuals with known hypersensitivity to any of its herbal components, by patients with severe liver disease without medical supervision, and by pregnant women unless the benefit outweighs the risk as assessed by a healthcare professional.